hairy cell leukemia


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to hairy cell leukemia: Cladribine

hairy cell leukemia

[¦her·ē ‚sel lü′kē·mē·ə]
References in periodicals archive ?
Treatment for hairy cell leukemia with cladribine was initiated after 10 weeks of antimicrobial drug treatment.
For B-cell LPDs other than CLL/SLL, several subtypes showed a cyclin D1/CD19 result in the low "MCL range" (RFI = 10-50), specifically one of the three hairy cell leukemia samples, one of the five diffuse large B-cell lymphomas, and one of the four follicular lymphomas, and "borderline" (RFI = 5-10) in one of the three hairy cell leukemia samples, three of five diffuse large B-cell lymphomas, one of five acute lymphoblastic leukemia samples, and one of two Burkitt lymphoma samples.
Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia.
Throughout the course of this event, her hairy cell leukemia remained stable.
BL22 singles out the molecule CD22, which appears on the surface of both hairy cell leukemia cells and a type of white blood cell called a B cell, Kreitman says.
Chronic lymphocytic leukemia Malignant lymphoma, leukemic phase Hairy cell leukemia Large granular lymphocytic leukemia Prolymphocytic leukemia Plasma cell leukemia Adult T-cell lymphoma-leukemia Mycosis fungoides/Sezary syndrome
A snapshot of the global therapeutic scenario for Hairy Cell Leukemia.
Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
antibody constructs and Amgen has received orphan drug designation from the FDA for the treatment of ALL, chronic lymphocytic leukemia (CLL), hairy cell leukemia, prolymphocytic leukemia and indolent B-cell lymphoma and from the European Medicines Agency for the treatment of indolent B-cell lymphoma, ALL, CLL and mantle cell leukemia (MCL).
The rule also expands the presumption for leukemia to include chronic B-cell leukemia, such as hairy cell leukemia.
To describe the key features and provide diagnostic clues to the identification of specific extranodal low-grade lymphomas of T-cell and B-cell types including small lymphocytic lymphoma, follicular lymphoma, mantle cell lymphoma, extranodal marginal zone B-cell lymphomas of mucosal-associated lymphoid tissue, and hairy cell leukemia.
The data reported demonstrate that 1D09C3 selectively induces programmed cell death (apoptosis) in a variety of xenotransplant lymphoid tumor models, including non-Hodgkin's lymphoma, Hodgkin's lymphoma, multiple myeloma, and hairy cell leukemia, as well as new data in Burkitt's lymphoma.